|
Erythroblastosis, Fetal
|
C16.300.060 |
|
|
Actins
|
D12.776.210.500.100 |
|
|
Muscle Proteins
|
D12.776.210.500 |
|
|
Phonophoresis
|
E02.319.267.700 |
|
|
Drug Administration Routes
|
E02.319.267 |
|
|
Abortifacient Agents, Steroidal
|
D27.505.954.705.131.200 |
|
|
Abortifacient Agents
|
D27.505.954.705.131 |
|
|
Lateral Medullary Syndrome
|
C23.550.513.355.250.100.500 |
|
|
Brain Stem Infarctions
|
C23.550.513.355.250.100 |
|
|
Eptifibatide
|
D000077542 |
[Cyclic peptide that acts as a platelet glycoprotein IIB-IIIA antagonist, reversibly inhibiting the binding of FIBRINOGEN; VON WILLEBRAND FACTOR; and other adhesive molecules to the GPIIB-IIIA RECEPTORS of platelets. It is used in the management of UNSTABLE ANGINA and in patients undergoing coronary ANGIOPLASTY and stenting procedures.
] |
|
Galactosylceramides
|
D09.400.410.420.525.200.250.450 |
|
|
Cerebrosides
|
D09.400.410.420.525.200.250 |
|
|
Eplerenone
|
D000077545 |
[A spironolactone derivative and selective ALDOSTERONE RECEPTOR antagonist that is used in the management of HYPERTENSION and CONGESTIVE HEART FAILURE, post-MYOCARDIAL INFARCTION.
] |
|
Roscovitine
|
D000077546 |
[A purine derivative and competitive inhibitor of CYCLIN-DEPENDENT KINASES that has therapeutic potential as an antineoplastic and antiviral agent.
] |
|
Deferiprone
|
D000077543 |
[A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
] |
|
Haemophilus parasuis
|
B03.660.250.550.290.700 |
|
|
Haemophilus
|
B03.660.250.550.290 |
|
|
Panitumumab
|
D000077544 |
[Recombinant human monoclonal antibody that binds to and inhibits the function of the EPIDERMAL GROWTH FACTOR RECEPTOR. It is used in the treatment of EGFR-expressing metastatic colorectal cancer that expresses wild-type ras gene (see GENES, RAS).
] |
|
Artemether
|
D000077549 |
[An artemisinin derivative that is used in the treatment of MALARIA.
] |
|
Eukaryotic Initiation Factor-5
|
D12.644.360.325.150.300 |
|
